SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-013573
Filing Date
2023-04-20
Accepted
2023-04-20 07:49:49
Documents
6
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy_statement.htm DEF 14A 1106410
2 GRAPHIC img99106014_0.jpg GRAPHIC 46243
3 GRAPHIC img99106014_1.jpg GRAPHIC 18406
4 GRAPHIC img99106014_2.jpg GRAPHIC 18406
5 GRAPHIC img99106014_3.jpg GRAPHIC 51519
6 GRAPHIC img99106014_4.jpg GRAPHIC 56570
  Complete submission text file 0000950170-23-013573.txt   1371494
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40067 | Film No.: 23831424
SIC: 2834 Pharmaceutical Preparations